These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1023 related articles for article (PubMed ID: 25941355)
1. The interplay of immunotherapy and chemotherapy: harnessing potential synergies. Emens LA; Middleton G Cancer Immunol Res; 2015 May; 3(5):436-43. PubMed ID: 25941355 [TBL] [Abstract][Full Text] [Related]
2. Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy. Wu J; Waxman DJ Cancer Lett; 2018 Apr; 419():210-221. PubMed ID: 29414305 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer. Ramakrishnan R; Gabrilovich DI Cancer Immunol Immunother; 2011 Mar; 60(3):419-23. PubMed ID: 20976448 [TBL] [Abstract][Full Text] [Related]
8. Combining immunotherapy and anticancer agents: the right path to achieve cancer cure? Apetoh L; Ladoire S; Coukos G; Ghiringhelli F Ann Oncol; 2015 Sep; 26(9):1813-1823. PubMed ID: 25922066 [TBL] [Abstract][Full Text] [Related]
9. Anticancer immunotherapy in combination with proapoptotic therapy. Bruserud Ø; Ersvaer E; Olsnes A; Gjertsen BT Curr Cancer Drug Targets; 2008 Dec; 8(8):666-75. PubMed ID: 19075589 [TBL] [Abstract][Full Text] [Related]
10. Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancer. Kerr MD; McBride DA; Chumber AK; Shah NJ Expert Opin Drug Discov; 2021 Jan; 16(1):89-99. PubMed ID: 32867561 [TBL] [Abstract][Full Text] [Related]
11. A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy. Robertson-Tessi M; El-Kareh A; Goriely A J Theor Biol; 2015 Sep; 380():569-84. PubMed ID: 26087282 [TBL] [Abstract][Full Text] [Related]
12. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches. Spigel DR; Socinski MA J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044 [TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy. McArthur HL; Page DB Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644 [TBL] [Abstract][Full Text] [Related]
14. Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system. Pico de Coaña Y; Choudhury A; Kiessling R Trends Mol Med; 2015 Aug; 21(8):482-91. PubMed ID: 26091825 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic cancer vaccines: a long and winding road to success. Baxevanis CN; Papamichail M; Perez SA Expert Rev Vaccines; 2014 Jan; 13(1):131-44. PubMed ID: 24224539 [TBL] [Abstract][Full Text] [Related]
16. Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer. Anagnostou VK; Brahmer JR Clin Cancer Res; 2015 Mar; 21(5):976-84. PubMed ID: 25733707 [TBL] [Abstract][Full Text] [Related]
17. Radiotherapy combined with immune checkpoint blockade immunotherapy: Achievements and challenges. Teng F; Kong L; Meng X; Yang J; Yu J Cancer Lett; 2015 Aug; 365(1):23-9. PubMed ID: 25980820 [TBL] [Abstract][Full Text] [Related]
18. How to improve the immunogenicity of chemotherapy and radiotherapy. Ma Y; Conforti R; Aymeric L; Locher C; Kepp O; Kroemer G; Zitvogel L Cancer Metastasis Rev; 2011 Mar; 30(1):71-82. PubMed ID: 21298323 [TBL] [Abstract][Full Text] [Related]